• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胆固醇:瑞士医生对血液水平及其控制]

[Cholesterol: blood level and control by Swiss physicians].

作者信息

Nigg C, Gutzwiller F

机构信息

Institut für Sozial- und Präventivmedizin, Zürich.

出版信息

Schweiz Med Wochenschr. 1995 Feb 25;125(8):355-60.

PMID:7709184
Abstract

The high coronary heart disease morbidity and mortality and the economic costs have led to intensive prevention efforts in Switzerland, where the management of multiple risk factors plays a prominent role. An important risk factor is hypercholesterolemia, one of the main causes in the development of human atherosclerosis. However, the eminence of this risk factor is not yet sufficiently established in the awareness of many physicians. Inappropriate public discussions of the problem have caused confusion among patients and physicians. Therefore, the purpose of the Cholesterin Informations Program of the Swiss Heart Foundation is to work out a far-reaching and objective information strategy for experts and the general population, based on scientific knowledge, as a contribution to promoting the health of the Swiss population.

摘要

冠心病的高发病率、高死亡率以及经济成本促使瑞士大力开展预防工作,在该国,对多种风险因素的管理发挥着重要作用。高胆固醇血症是一个重要的风险因素,是人类动脉粥样硬化发展的主要原因之一。然而,许多医生尚未充分认识到这一风险因素的重要性。对该问题不恰当的公开讨论在患者和医生中造成了困惑。因此,瑞士心脏基金会胆固醇信息项目的目的是,基于科学知识,为专家和普通民众制定一项影响深远且客观的信息战略,以促进瑞士民众的健康。

相似文献

1
[Cholesterol: blood level and control by Swiss physicians].[胆固醇:瑞士医生对血液水平及其控制]
Schweiz Med Wochenschr. 1995 Feb 25;125(8):355-60.
2
[Current developments in prevention of coronary heart disease].[冠心病预防的当前进展]
Z Arztl Fortbild (Jena). 1996 Feb;90(1):7-10.
3
[Cholesterol and coronaropathy].[胆固醇与冠状动脉疾病]
G Ital Cardiol. 1993 Mar;23(3):221-4.
4
Blood cholesterol and coronary heart disease: changing perspectives.血液胆固醇与冠心病:不断变化的观点
J R Soc Med. 1994 Aug;87(8):450-3.
5
Cholesterol consensus: a trans-Atlantic perspective. Amsterdam, The Netherlands, 31-October-1 November 1991.胆固醇共识:跨大西洋视角。荷兰阿姆斯特丹,1991年10月31日至11月1日。
Int J Cardiol. 1992 Oct;37 Suppl 1:S1-37; discussion S38-54.
6
[Cholesterol non-consensus in primary prevention of coronary heart disease. Methodologic problems in the interpretation of epidemiologic studies].
Z Kardiol. 1993 Jul;82(7):399-405.
7
Cholesterol education program in the United States.
Can J Cardiol. 1988 Jul;4 Suppl A:31A-35A.
8
Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults.
Circulation. 2003 Nov 25;108(21):e152; author reply e152. doi: 10.1161/01.CIR.0000100889.17580.82.
9
[The lowering of serum cholesterol in the prevention of coronary disease (part 1). The Canadian Study Group for Periodic Medical Examinations].[血清胆固醇降低在冠心病预防中的作用(第1部分)。加拿大定期体检研究组]
Union Med Can. 1994 Apr;123(4):249-58.
10
[Prognostic significance of total blood cholesterol level and the possibility of dietary correction of hypercholesterolemia in the population].[总血胆固醇水平的预后意义及人群中高胆固醇血症饮食纠正的可能性]
Kardiologiia. 1989 Jun;29(6):28-32.